WSA
ACGN

Wall Street Associates’s Aceragen Inc ACGN Stock Holding History

Wall Street Associates’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,944
Closed -$1.02M – 215
2016
Q3 		$1.02M Hold
2,944
– – 0.35% 103
2016
Q2 		$612K Hold
2,944
– – 0.24% 112
2016
Q1 		$792K Hold
2,944
– – 0.33% 104
2015
Q4 		$1.24M Sell
2,944
-736
-20% -$329K 0.35% 104
2015
Q3 		$1.68M Hold
3,680
– – 0.32% 94
2015
Q2 		$1.85M Hold
3,680
– – 0.17% 138
2015
Q1 		$1.85M Hold
3,680
– – 0.18% 148
2014
Q4 		$2.21M Hold
3,680
– – 0.21% 137
2014
Q3 		$1.15M Hold
3,680
– – 0.12% 192
2014
Q2 		$1.45M Hold
3,680
– – 0.12% 190
2014
Q1 		$2.04M Buy
+3,680
New +$2.52M 0.17% 174

Other funds holding ACGN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wall Street Associates's ACGN Position: Q4 2016 in Review

Wall Street Associates sold out of Aceragen Inc (ACGN) in Q4 2016, closing a stake of 2,944 shares — an estimated $1.02M sold.

Wall Street Associates first reported a position in ACGN in Q1 2014 and held it in 11 quarters. The position peaked at $2.21M in Q4 2014. 83 funds tracked by Wall St. Rank hold ACGN as of Q4 2016.

  • Wall Street Associates reported no remaining Aceragen Inc position as of Q4 2016 after selling out during the quarter.
  • Wall Street Associates sold 2,944 Aceragen Inc shares in Q4 2016, an estimated $1.02M.
  • Wall Street Associates first reported a position in Aceragen Inc in Q1 2014 and held it in 11 quarters.
  • Wall Street Associates's Aceragen Inc position peaked at $2.21M in Q4 2014.
  • 83 funds tracked by Wall St. Rank held Aceragen Inc as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.